FERNANDO
ARÓS BORAU
Investigador hasta 2018
Harvard Medical School
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Harvard Medical School (8)
2021
-
Lipid Profiles and Heart Failure Risk: Results From Two Prospective Studies
Circulation Research, Vol. 128, Núm. 3, pp. 309-320
2019
-
High plasma glutamate and low glutamine-to-glutamate ratio are associated with type 2 diabetes: Case-cohort study within the PREDIMED trial
Nutrition, Metabolism and Cardiovascular Diseases, Vol. 29, Núm. 10, pp. 1040-1049
-
Plasma acylcarnitines and risk of type 2 diabetes in a mediterranean population at high cardiovascular risk
Journal of Clinical Endocrinology and Metabolism, Vol. 104, Núm. 5, pp. 1508-1519
-
Plasma metabolites associated with coffee consumption: A metabolomic approach within the PREDIMED study
Nutrients, Vol. 11, Núm. 5
2018
-
Association of tryptophan metabolites with incident type 2 diabetes in the PREDIMED trial: A case–cohort study
Clinical Chemistry, Vol. 64, Núm. 8, pp. 1211-1220
-
Lipid metabolic networks, Mediterranean diet and cardiovascular disease in the PREDIMED trial
International Journal of Epidemiology, Vol. 47, Núm. 6, pp. 1830-1845
2017
-
Plasma lipidomic profiles and cardiovascular events in a randomized intervention trial with the Mediterranean diet
American Journal of Clinical Nutrition, Vol. 106, Núm. 4, pp. 973-983
-
Total and subtypes of dietary fat intake and risk of type 2 diabetes mellitus in the Prevencí on con Dieta Mediterŕanea (PREDIMED) study
American Journal of Clinical Nutrition, Vol. 105, Núm. 3, pp. 723-735